ALDH Inhibitors to Promote Immune Cell Expansion
AssigneeUniversity of Pittsburgh—Of the Commonwealth System of Higher Education
InventorsRonald J. Buckanovich, Anda Mioara Vlad
Life of this patent
Estimating the term…
Abstract
Using an aldehyde dehydrogenase-1A enzyme inhibitor (ALDHi) for expanding bone marrow cells and/or dendritic cells and for adjuvant therapy to an immunotherapy
Claims29
A method of expanding bone marrow cells and/or dendritic cell populations, comprising culturing bone-marrow cells and/or dendritic cells in culture medium comprising an amount of an Aldehyde dehydrogenase-1A enzyme inhibitor (ALDHi) effective to increase a population of the bone-marrow cells and/or dendritic cells as compared to an increase in the population of the bone-marrow cells and/or dendritic cells grown in the same culture medium and conditions without the ALDHi in the culture medium.
3-8. (canceled)
(canceled)
An immunotherapy method for increasing an immune response to a pathogen or cancer cell antigen in a patient, comprising:
- administering to a patient an immunotherapeutic agent for increasing an antigen-specific immune response in a patient;
- and
- administering to the patient an adjuvant therapy to the administration of the immune cell, an amount of an aldehyde dehydrogenase-1A enzyme inhibitor (ALDHi) effective to reduce TREG activity in the patient.
19-23. (canceled)
25-30. (canceled)
(canceled)
36-38. (canceled)
41-42. (canceled)
(canceled)
46-47. (canceled)
Dependencies are inferred from the claim text.